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   The nutritional requirements generally satisfied by serum in established 
cultures of human hematopoietic cells were studied in spinner culture. The 
optimum concentration of fetal calf serum for cell proliferation in medium 
RPMI #1640 appeared to be 20%, and the minimum to be 2%. In the loga-
rithmic phase of cell growth, there was an exponential increase of protein 
in the cells and a corresponding decrease in the medium. Immunoglobulin 
production in one cell line was highest in the logarithmic phase of cell 
growth and in the culture medium supplemented with serum at a low level. 
The rate of cell proliferation under various culture conditions bears some 
relationship to the rate of immunoglobulin production in these cell lines.
                  INTRODUCTION 
   A number of human hematopoietic cell lines have been originated 
from the huffy coat of peripheral leukocytes from patients with diverse 
clinical diseases, leukemia, and even from healthy individuals' 3' 
Because of their unique properties, such as immunoglobulin production4-
91 and the frequent presence of a herpes-type virus'O,11' , great interest 
has been focused on these lines. Recent experiments in our laboratory 
have shown that some human hematopoietic cells grow in chemically 
defined media without supplementation with serum or other macromole-
cules. 
   The present study is concerned with the effects of various concent-
rations of serum in the medium on cell growth in suspension culture. 
Growth rate was correlated with the functional activity of the cells 
under various nutritional conditions by evaluating u-chain reactive
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immunoglobulin production with immunofluorescence methods. 
              MATERIALS AND METHODS 
   The human lymphoblastoid cell lines used in this study were RPMI 
#5328, 04265, and #7206`11. RPMI #5328 was derived from the periphe-
ral blood of a patient with an acute myelogenous leukemia, # 4265 from a 
patient with a chronic myelogenous leukemia, and #7206 from a healthy 
individual. The procedures for establishment and maintenance and the 
general characteristics of these cell lines have been reported' . The 
karyotypes of the cells have been diploid more than 2 years. 
   Medium RPMI #16402, supplemented with 10% (V/V) heat-inactiva-
ted fetal calf serum or adult human serum (GIBCO) was used in 50-m1 
spinner flasks . The cell suspension contained 3 - 5 x 105 cells per ml 
with a viability of 95% or more which was estimated by the dye exclu-
sion method, and the pH was adjusted to 7.3. The flasks were incu-
bated in a spinner box with the magnetic stirrer at 37°C without 
refeeding for 7 days. Cell growth and viability were determined with 
the use of hemocytometer by the trypan blue exclusion test. 
                     RESULTS 
   Growth behavior in spinner flasks was generally similar for the 
three cell lines. The cells grew only in suspension, without adherence 
to the glass vessel, but with some clumping that could be easily elimi-
nated by shaking. 
   With inocula ranging from 3 to 5x101 cells/ml, growth was slow 
in the first 24 hours (lag phase), but exponential for the next 3 days, 
and then showed a plateau phase, followed by deterioration. With an 
inoculum of more than 5 x 105 cells/ml, the lag period was absent, and 
the exponential phase was brief. With an initial inoculum of less than 
3x10-' cells/ml, the doubling time was prolonged, and the exponential 
phase extended for more than 3 days. If the inoculum was smaller 
than 0.5x101 cells/ml, the cells did not grow. It seemed desirable to 
use inocula ranging from 3 to 5 x 105 cells/ml for the purpose of the 
present study. The maximal cell populations attained were about 3 x 
101 cells/ml, regardless of the initial cell population. 
    Effects of serum and serum substitutes. Fig. 1 and 2 show represen-
tative results for cell line RPMI #5328 with various concentrations of 
fetal calf or adult human serum. The various concentrations provided 
similar growth patterns. Growth was greater in medium supplemented 
with 5, 10, 20, or 40% fetal calf serum than in medium with 1 or 2% 
serum. Medium without serum supplementation did not support cell
growth, and did not even maintain the original viability of the cell 
population. The doubling time during the exponential growth period 
was about 25.5 hours. The cells grew faster with 2 % adult human 
serum than with 2% fetal calf serum. 
 Various concentrations of bovine albumin (Pentex), lactalbumin hydro-
lysate (NBC), and bactopeptone (NBC) were added to medium RPMI 
01640 without serum. Although some differences among the 3 cell lines
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FIGS. I and 2. Growth curves for cell line RPMI #5328, with various concentra-
    tions of fetal calf serum (Fig. 1) and adult human serum (Fig. 2). 
      FCS, % fetal calf serum in medium RPMI #1640; HS, % human serum in 
    medium RPMI $$1640.
tested were found in the maximal cell population, the optimum concent-
rations of these supplements were 0.07% for bovine albumin, 0.2% for 
lactalbumin hydrolysate, and 0.1% for bactopeptone medium. These 
substances temporarily supported a low rate of proliferation of the cells 
in the absence of serum, but were not as effective as 2% serum. A 
combination of these supplements was not beneficially. 
   Medium supplemented with bovine albumin, lactalbumin hydrolysa-
te, or bactopeptone at an optimum level contained about 700 ag/ml 
protein as determined by the method of Lowry et al. 12' . This protein 
concentration, which seemed to be optimal for cell growth, was equival-
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   Fig. 2.
by centrifugation at 1,500 rpm for 10 minutes. The packed cells were 
washed 3 times with phosphate buffer solution before protein assay. 
   Figs. 3 and 4 show the changes in the protein contents of the cells 
and medium during continuous cultivation. During the period of cell 
proliferation, the growing cells consumed some protein from the me-
dium, and their protein content increased. During the phase of cell
Fig. 3.
FIGS. 3 and 4. Serum protein consumption during continuous cultivation of cell 
    line RPMJ $$4265 in medium containing 10% (Fig. 3) and 2% (Fig. 4) fetal 
     calf serum. 
       (A) Relationship between changes in cell protein content and cell prolifera-
     tion. Protein content represents the mean of 3 samples ; standard deviation 
     ±8.3 in both figures. (B) Changes in protein content in cell-free supernatant 
     medium. Protein content represents the mean of 3 samples; standard deviation 
     ±83.0 in Fig. 4 and ±33.2 in Fig. 5. (C) Changes in ratio of protein content 
     to number of cells.
ent to 2 % fetal calf serum or 1 % adult human serum. The latter 
concentrations of serum appeared to be the minimums required for 
good cell growth, even though serum protein probably not only serves 
as a nutrient, but also provides osmotic support and may be a carrier 
of unidentified growth factors. It was interesting that little difference 
in effectiveness was found between 2% fetal calf serum and 1% adult 
human serum. 
   Serum protein consumption. Protein contents of cells and cell-free 
medium were determined by a modification of the method of Lowry et 
al."' in order to evaluate serum protein consumption by the cells. 
Spent medium with the cells was separated into cells and supernatant 
growth decline, however, the protein content of the medium increased, 
as might be expected as a result of protein release from degenerating 
cells, The ratio of the protein content of the cells to the cell population 
proved to be higher in the early period of logarithmic cell growth than
Fig 4.
in the late period. The total protein content of the culture decreased 
during cell growth, but an equivalent relationship could not be found 
between the increased protein content of cells and the decreased protein 
content of the medium during cell proliferation. After 4 days of culti-
vation , determinations of protein in cells and medium maybe inaccurate 
because of increasing proportions of dead cells and debris. 
   Cellular immunoglobulin levels, Human hematopoietic cell lines syn-
thesize diverse classes of immunoglobulins9'. Cell line RPMI #4265 
reacted strongly with anti-human u chain reagent (goat anti-human ,v 
chain labeled with fluorescein isothiocyanate, Hyland Laboratories). 
   Figs. 5-7 show kinetic analyses of population growth, cell viability, 
and percentage of immunoglobulin-positive cells in medium supplemented 
with 10, 2, or 0% fetal calf serum. It should be kept in mind that 
immunofluorescence reflects the presence of reactive antigen and does 
not indicate active synthesis at the time of determination. The percen-
tage of immunoglobulin-positive cells proved to be highest in ,the loga-
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FIGS. 5-7. Relationships among changes in cell proliferation, cell viability, and 
    number of immunoglobulin-positive cells in medium containing 10% (Fig. 5), 
    2% (Fig.6), and 0% (Fig. 7) fetal calf serum. 
      (a) Cell viability (%). (b) Number of viable cells per milliliter. (c) Per-
     centage of immunoglobulin-positive cells among total viable cells. (d) Number 
     of immunoglobulin-positive cells per milliliter.
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     Fig. 7.
rithmic phase of cell proliferation and in medium containing 2% fetal 
calf serum. 
   The rate of cell proliferation paralleled the number of immunoglo-
bulin-positive cells in serum containing medium. In serum-free medium, 
however, immunoglobulin-positive cells remained at a relatively high 
level during the decline in both population and viability. Caution must 
be used in setting aside false positive fluorescent reactions of dying cells. 
   Adult human serum provided results similar to those provided by 
fetal calf serum. 
                    DISCUSSION 
   The present study demonstrates that 2% is the minimal concentra-
tion of fetal calf serum required in medium RPMI #1640 for spinner 
cultures of the homan hematopoietic cell lines RPMI 05328, 04265, and 
07206. Human serum was a suitable supplement at a level of 1%. The 
3 cell lines differed in their ability to adapt themselves to media with 
low concentrations of serum (unpublished data). 
   During the logarithmic phase of cell growth, there was a parallel 
increase in cellular protein and a decrease of the protein in the medium. 
In media containing 10 and 2% serum respectively, however, the cells 
did not always consume the expected amount of serum protein during 
cell proliferation. These observations suggest that the cells were absor-
bing some components of proteins or were incorporating the products of 
proteolysis13' . In the declining phase of the cultures, the protein 
content of the medium increased. Since there was a tendency for the 
total protein content of the whole culture to decrease, the changes in 
the cell proteins may have been due to proteolysis rather than absorp-
tion of proteins into cells. 
   The incorporation of tagged protein components from the medium 
into cellular protein has indicated significant utilization by certain cell 
lined`" . Nevertheless, the contribution of dialyzed protein as an added 
nitrogen source was very minor for HeLa cell cultures 151 , and the 
replacement of serum proteins with other kinds of macromolecules 
unrelated to cell nutrition was successful in some instances"'. The 
data presented are far from uniform, despite the similarity in the 
experiments. Author's experimental results suggest the both the entry 
of proteins into cells in the stage of protein synthesis and the release of 
proteins from cells in the stage of degeneration. 
   Growth rate, change in cell viability, and the presence of immuno-
globulin were studied comparatively in cultures supplemented with 
various concentrations of serum. Immunoglobulin production was pro-
portional to the rate of cell proliferation in medium containing serum. 
In the medium containing serum at a low concentration, the ratio of
immunoglobulin-positive cells to total viable cells rose to an extremely 
high level, and the total number of cells producing immunoglobulin 
showed a maximal increase on the 4th day of culture, despite a reduc-
tion in growth and viability. If immunoglobulin is released into the 
medium from degenerating cells, a high percentage of immunoglobulin-
positive cells may result from these cells continuing in the stage of 
immunoglobulin production and storage for a long time prior to death, 
since their presence in culture medium containing low levels of serum 
could be due to release from dead cells. 
   The more immunoglobulin production by cells in the logarithmic 
phase of cell proliferation suggests that vigorous cell metabolism tends 
to increase immunoglobulin production. It would seem that non-produ-
cing cells that react to an antibody reagent might have some potential 
capability for producing immunoglobulin. Immunoglobulin-producing 
activity has been shown to vary during culture5'8'9' . Furthermore, 
the immunoglobulin production by the cells in vitro may apparently 
related to their metabolism and protein synthesis apart from cell divi-
sion, but it was difficult to evaluate the functional state of cells in any 
specific stage of cultivation. 
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